Paul Nestel Selected Research

tetrahydrodaidzein

5/2007	An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women.
9/2004	Angioplasty-induced superoxide anions and neointimal hyperplasia in the rabbit carotid artery: suppression by the isoflavone trans-tetrahydrodaidzein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Nestel Research Topics

Disease

10	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 03/2003
8	Coronary Disease (Coronary Heart Disease) 01/2020 - 02/2003
4	Atherosclerosis 02/2013 - 04/2002
3	Inflammation (Inflammations) 12/2015 - 04/2008
3	Myocardial Infarction 12/2015 - 10/2013
3	Insulin Resistance 04/2011 - 03/2003
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2008 - 03/2003
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 04/2008
2	Unstable Angina 02/2014 - 10/2013
2	Hyperplasia 05/2009 - 09/2004
2	Neointima 05/2009 - 09/2004
2	Overweight 04/2008 - 05/2007
1	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 01/2019
1	Acute Coronary Syndrome 12/2015
1	Vascular Diseases (Vascular Disease) 02/2013
1	Dyslipidemias (Dyslipidemia) 12/2006
1	Stroke (Strokes) 07/2006
1	Pathologic Constriction (Stenosis) 09/2004
1	Hypertension (High Blood Pressure) 03/2003
1	Glucose Intolerance 03/2003

Drug/Important Bio-Agent (IBA)

8	CholesterolIBA 02/2014 - 04/2002
6	LipidsIBA 01/2020 - 07/2006
4	Pravastatin (Pravachol)FDA LinkGeneric 12/2015 - 07/2006
4	Lipoproteins (Lipoprotein)IBA 03/2014 - 03/2003
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2008 - 07/2006
3	IsoflavonesIBA 05/2007 - 02/2003
2	LDL CholesterolIBA 02/2013 - 07/2006
2	CarbohydratesIBA 04/2011 - 03/2004
2	AntioxidantsIBA 05/2009 - 04/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2009 - 09/2004
2	tetrahydrodaidzeinIBA 05/2007 - 09/2004
2	Glucose (Dextrose)FDA LinkGeneric 09/2006 - 03/2004
1	CeramidesIBA 01/2020
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020
1	Lipoprotein(a)IBA 11/2019
1	Cholesterol Ester Transfer ProteinsIBA 01/2019
1	HDL LipoproteinsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	crotalid hemorrhagic factor AIBA 08/2015
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 08/2015
1	Trans Fatty AcidsIBA 03/2014
1	Plant Oils (Vegetable Oils)IBA 03/2014
1	oxidized low density lipoproteinIBA 03/2014
1	Troponin IIBA 02/2014
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 10/2013
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 02/2013
1	Phytosterols (Plant Sterols)IBA 02/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2011
1	FatsIBA 06/2009
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2009
1	NF-kappa B (NF-kB)IBA 05/2009
1	Rosuvastatin Calcium (Crestor)FDA Link 04/2008
1	daidzeinIBA 05/2007
1	Triglycerides (Triacylglycerol)IBA 12/2006
1	HDL CholesterolIBA 12/2006
1	Conjugated Linoleic AcidsIBA 12/2006
1	ChylomicronsIBA 12/2006
1	Apolipoproteins E (ApoE)IBA 12/2006
1	coenzyme Q10 (CoQ10)IBA 07/2006
1	CollagenIBA 09/2004
1	AnionsIBA 09/2004
1	Superoxides (Superoxide)IBA 09/2004
1	Insulin (Novolin)FDA Link 03/2004

Therapy/Procedure

3	Therapeutics 11/2019 - 03/2003
1	Secondary Prevention 08/2015
1	Aftercare (After-Treatment) 04/2008
1	Catheters 09/2004